Francesca Arensi - Senior Site Contracts Specialist - Syneos Health Clinical Solutions | LinkedIn
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) - Gynecologic Oncology
New Clinic In Miami Extends inVentiv Health Phase I Services To The US
Andrea Chifenti - Clinical trial Manager I - Syneos Health | LinkedIn